More on GRAL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+19.5% Growth)
- Ratings (4.4 Score)

Upcoming Events

- Earnings (11/12/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

GRAIL, Inc. (NQ:GRAL)
Delayed: 68.41 -0.53 (0.77%)
Prev. Close $68.94  
Open$68.94 
52 Wk High$ 
52 Wk Low$ 
Day High$69.99 
Day Low$67.34 
P/E N/A  
EPS$ 
Volume218,581 

Friends, Peers and Foes (?): GRAL.V, WGS, BMI, VRRM, PSIX (more...)

Aug 7, 2026 11:05 AM FDA panel set to review GRAIL's multi-cancer blood test application
Aug 7, 2026 11:05 AM GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
Aug 7, 2026 09:44 AM Form SCHEDULE 13G GRAIL, Inc. Filed by: STATE STREET CORP
Aug 6, 2026 05:02 PM Form SCHEDULE 13G/A GRAIL, Inc. Filed by: PRIMECAP MANAGEMENT CO/CA/
Aug 6, 2026 04:17 PM Form 10-Q GRAIL, Inc. For: Jun 30
Aug 5, 2026 04:15 PM GRAIL, Inc. (GRAL) Reports Q2 Loss of $2.56
Aug 5, 2026 04:12 PM Form 8-K GRAIL, Inc. For: Aug 05
Aug 5, 2026 04:02 PM GRAIL Reports Second Quarter 2026 Financial Results
Jul 30, 2026 04:01 PM GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference
Jul 29, 2026 04:01 PM GRAIL to Announce Second Quarter 2026 Financial Results
View All Articles

Entities mentioned with GRAL

View All Entities